The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat

(2011) Axel Fun et al.   Retrovirology

Phenotypic Susceptibility to Bevirimat in Isolates from HIV-1-Infected Patients without Prior Exposure to Bevirimat

(2010) N. A. Margot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

HIV-1 Maturation Inhibitor Bevirimat Stabilizes the Immature Gag Lattice

(2010) P. W. Keller et al.   JOURNAL OF VIROLOGY

Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat

(2010) Catherine S. Adamson et al.   Retrovirology

Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1

(2009) K. Van Baelen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The structural biology of HIV assembly

(2008) Barbie K Ganser-Pornillos et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY